Changes in Sexual Response and Orgasm on GLP-1s: What Patients Report
Most people who lose meaningful weight report that sex gets better, and improvements in arousal and orgasm are a real part of that. The…
Vaginal Odor Changes on GLP-1 Medications: What’s Normal and What’s Not
If you’ve noticed a shift in vaginal odor since starting a GLP-1 medication, you’re not imagining a connection, though the link is indirect. GLP-1…
Can Losing Weight on GLP-1s Improve Bladder Leakage? Stress Incontinence Explained
Yes, losing weight is one of the most reliably effective things you can do for stress urinary incontinence, and GLP-1 medications produce exactly the…
Pelvic Floor Health and GLP-1 Weight Loss: What Actually Changes
Losing weight on a GLP-1 medication takes real, measurable pressure off your pelvic floor, and for many people that translates into fewer symptoms like…
Does GLP-1 Weight Loss Improve Erectile Dysfunction? What Men Should Know
For many men, losing a significant amount of weight on a GLP-1 medication does improve erectile function, though the reason has more to do…
What Is Amycretin? Novo’s Next-Generation Amylin-GLP-1 Drug
Amycretin is an investigational obesity drug from Novo Nordisk that combines two appetite-regulating mechanisms, GLP-1 and amylin, in a single molecule, and it comes…
What’s Coming After Ozempic and Zepbound: The 2026 Weight Loss Drug Pipeline
The obesity drug pipeline in 2026 is the most active it has ever been, with several new medications either just approved or moving through…
What Is Survodutide? The GLP-1/Glucagon Drug for Obesity and Liver Disease
Survodutide is an investigational once-weekly injectable from Boehringer Ingelheim and Zealand Pharma, being developed for both obesity and liver disease. It’s a dual agonist…
Orforglipron vs Ozempic: Pill vs Injection for Weight Loss
Orforglipron and Ozempic both harness GLP-1 to reduce appetite and drive weight loss, but they differ in two ways that matter day to day:…
